COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Comment by plovieon Apr 04, 2007 8:04am

70 Views

Post# 12544769

RE: very lax-FROM THE WEBSITE

Hey Genius, Gagnon, who joined AEterna Zentaris in 1999 and became the president and CEO in 2003, will continue to work with the company as a consultant. He will still be working with the company. You must have never dealt in business before. I'm sure that Gagnon has developed some relationships with other companies and other CEO's. They don't want to just rip his name off everything in one day. It is called "transition". Plus it is irrelevant! The only thing that matters right now is the drugs that are in Phase 2 and Phase 3.

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features